Armata Pharmaceuticals, Inc. — Director's Dealing 2008

May 19, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2008-05-15

Reporting Person: CARTER BARRIE J PHD (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-05-15	Common Stock	A	35000	$0.00	Acquired	83766	Direct

Footnotes

F1: These shares represent a grant of restricted stock units that vest in three substantially equal installments on each of May 15, 2009, May 15, 2010 and May 15, 2011, the vesting of which shall accelerate upon a change of control, so long as the reporting person is providing services to the issuer on such dates.